Avalon Global Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-100,000
Closed -$8.49M 34
2021
Q3
$8.49M Buy
100,000
+20,000
+25% +$1.68M 1.36% 30
2021
Q2
$6.67M Sell
80,000
-20,000
-20% -$1.64M 1.11% 35
2021
Q1
$7.52M Buy
+100,000
New +$7.28M 1.32% 33
2020
Q3
Sell
-100,000
Closed -$6.5M 47
2020
Q2
$6.5M Buy
+100,000
New +$6.3M 2.11% 20
2019
Q2
Sell
-120,000
Closed -$6.47M 38
2019
Q1
$6.47M Buy
+120,000
New +$7.41M 3.45% 13

Other funds holding CVS

Avalon Global Asset Management's CVS Position: Q2 2020 in Review

Avalon Global Asset Management sold out of CVS Health (CVS) in Q2 2020, closing a stake of 76,600 shares — an estimated $4.82M sold.

Avalon Global Asset Management first reported a position in CVS in Q1 2018 and held it in 8 quarters. The position peaked at $9.45M in Q3 2018. 1,863 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

  • Avalon Global Asset Management reported no remaining CVS Health position as of Q2 2020 after selling out during the quarter.
  • Avalon Global Asset Management sold 76,600 CVS Health shares in Q2 2020, an estimated $4.82M.
  • Avalon Global Asset Management first reported a position in CVS Health in Q1 2018 and held it in 8 quarters.
  • Avalon Global Asset Management's CVS Health position peaked at $9.45M in Q3 2018.
  • 1,863 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on Avalon Global Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.